TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Cravings for cigarettes
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: NF-kappaB activity in peripheral blood monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recognition rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: systemic vascular resistances
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of dietary fat intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Post-methionine load homocysteine concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Longest hop distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Torque change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optical clarity during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c (A1C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Upper limb tremor improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of confirmed arthritis of any type
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aspirated secretion amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean dynamic compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: expired tidal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak inspiratory pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of temperature increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall arm motor recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: platelet aggregation response to ADP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time until TVR decreased below 40 ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Occurrence of hypothyroidism
Endpoint domain: Adverse events/effects
Primary endpoint: weekly mean leg pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in radiation-induced xerostomia symptom burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RMS (Root Mean Square)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: MTS (Muscle Tone Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pitch Range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WSRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall recurrence rates
Endpoint domain: Mortality/survival
Primary endpoint: changes in blood uric acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sample size requirements
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Success rates of antidepressant trials
Endpoint domain: Mortality/survival
Primary endpoint: Time required for home readiness
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in DAS28‐CRP from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving EULAR good/moderate responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with at least one treatment‐emergent adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Mean MEP amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensory threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Easier PEG intake
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diet compliance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: global insomnia symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: general sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: sleep-disruptive beliefs
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean peak intraocular pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Net increase in intraocular pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Cognitive tests of attention and impulsivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Children's ability to work more productively
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: total PSPRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall reduction in wound burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of wounds expected to heal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in fasting insulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: total bilirubin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GGTP concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EIB protection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative ICS dose
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Self-reported function (WOMAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk for viral drug resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: E-selectin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Vascular responses to acetylcholine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Increase in red blood cell folate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Post-Traumatic Growth (PTG) levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: BMI and survival association
Endpoint domain: Mortality/survival
Primary endpoint: Food allergy prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of IgE-associated eczema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Readmission for intractable vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: DHA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Functional mobility capacity improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait performance improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived risks and benefits of quitting smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: weight gain concerns upon quitting
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: negative affect upon quitting
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Weighted sum of pain intensity differences over 24 hours (SPID24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to meaningful pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiologic cure at urogenital sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in confidence to use reminder/recall systems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction measures such as convenience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Delivery cost per clinic
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: reduction in acetaminophen-related morbidity and mortality
Endpoint domain: Mortality/survival
Primary endpoint: Risk of Surgical Site Infection (SSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean cumulative abstinence duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate at submaximal exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: First attempt intubation success rate within 30 seconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First attempt intubation success rate within 60 seconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound pain score
Endpoint domain: Adverse events/effects
Primary endpoint: Mediastinal drain output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Plasma alkaline phosphatase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Patient satisfaction with implant-retained denture
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Probing depths around implants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptomatic treatment of PD symptoms required
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Study treatment prematurely discontinued
Endpoint domain: Adverse events/effects
Primary endpoint: Maintaining sinus rhythm (SR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of radiologically detected progression of disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mental health stigma
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effect of anticonvulsants in diabetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect of antidepressants with duration of pain less than 3 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of PTB <35 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Episodes of health service use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total annual costs of care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Receipt of surveillance mammography
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Clinical remission and endoscopic improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with analgesia method
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Correct identification of lung area markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to identify lung area markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalization for RSV bronchiolitis in infancy
Endpoint domain: Mortality/survival
Primary endpoint: 8-year survival probability
Endpoint domain: Mortality/survival
Primary endpoint: Plaque accumulation parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding index values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erythrocyte velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Annual WMH volume increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of new lacunar infarcts
Endpoint domain: Adverse events/effects
Primary endpoint: Self-reported premenstrual exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in attendees
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exacerbation of asthma requiring treatment with oral corticosteroids
Endpoint domain: Adverse events/effects
Primary endpoint: reserve capacity measured by difference scores of swallowing pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cerebral atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence of periventricular white matter lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Free recall of information
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Haemoglobin level on day 180
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: lower milk loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: longer milk ingestion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower frequency of complications during feeding
Endpoint domain: Adverse events/effects
Primary endpoint: increased energy levels
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: improved self-awareness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Bacterial diversity in GUD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 9-OH risperidone clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Choice of unadvertised drugs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Choice of over-the-counter drugs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: daily hair loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vertex hair density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frontal hair density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved physical functions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functional improvement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Light-headedness
Endpoint domain: Adverse events/effects
Primary endpoint: Pap smear completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of visitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: supplemental analgesics consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Dialyzer clearance of β2‐microglobulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dialyzer clearance of cystatin c
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of serum levels of β2‐microglobulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of serum levels of cystatin c
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccination coverage rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mucous coating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lens binding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SGRQ-C symptom scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fasting Triglycerides (TG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Seropositivity for CagA bearing strains of H pylori
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of wound area reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean hospitalization days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: AGE-forming capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma fluorescence (AGE compounds)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CA 125 concentrations in spent dialysate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hourly pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in tumor mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Expressive suppression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SRQ scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: TSH levels >30 μU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: final stimulated THW-Tg ≥2 ng/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduced risk of FDE
Endpoint domain: Mortality/survival
Primary endpoint: Mean apparent terminal phase half-life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cue-induced cortisol response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Symptoms of oral mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality rate after elective anterior resection
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of clinical anastomotic leakage
Endpoint domain: Adverse events/effects
Primary endpoint: Delta STmax (maximum ST elevation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sigma ST (sum of ST elevation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: stable glycemic control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: any bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: access-site bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: non-access-site bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: ambulation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urination time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative itching
Endpoint domain: Adverse events/effects
Primary endpoint: Current health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physical Health Component Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean Raynaud's Condition Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean frequency of Raynaud attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean capillary flow velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain and discomfort during x-ray
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted mean difference in alcohol consumption after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unprotected sex reported
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Undetectable serum thyroglobulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients remaining exacerbation-free
Endpoint domain: Mortality/survival
Primary endpoint: Control of negative symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in rigidity and akathisia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Vester‐Andersen's criteria met
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of sensory blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of motor blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inability to open eyes on command
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Corvis‐ST biomechanically corrected IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central pachymetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal first applanation stiffness parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FSH/LH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: PSV (Peak Systolic Velocity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AFC (Antral Follicle Count)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in dentin sensitivity (DS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes